» Articles » PMID: 20110414

Alternatively Activated Macrophages and Collagen Remodeling Characterize the Postpartum Involuting Mammary Gland Across Species

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2010 Jan 30
PMID 20110414
Citations 165
Authors
Affiliations
Soon will be listed here.
Abstract

Recent pregnancy correlates with decreased survival for breast cancer patients compared with non-pregnancy-associated breast cancer. We hypothesize that postpartum mammary involution induces metastasis through wound-healing programs known to promote cancer. It is unknown whether alternatively activated M2 macrophages, immune cells important in wound-healing and experimental tumorigenesis that also predict poor prognosis for breast cancer patients, are recruited to the normal involuting gland. Macrophage markers CD68, CSF-1R, and F4/80 were examined across the pregnancy and involution cycle in rodent and human mammary tissues. Quantitative immunohistochemistry revealed up to an eightfold increase in macrophage number during involution, which returned to nulliparous levels with full regression. The involution macrophages exhibit an M2 phenotype as determined by high arginase-1 and low inducible nitric oxide synthase staining in rodent tissue, and by mannose receptor expression in human breast tissue. M2 cytokines IL-4 and IL-13 also peaked during involution. Extracellular matrix (ECM) isolated from involuting rat mammary glands was chemotactic for macrophages compared with nulliparous mammary ECM. Fibrillar collagen levels and proteolysis increased dramatically during involution, and denatured collagen I acted as a strong chemoattractant for macrophages in cell culture, suggesting proteolyzed fibrillar collagen as a candidate ECM mediator of macrophage recruitment. M2 macrophages, IL-4, IL-13, fibrillar collagen accumulation, and proteolysis of collagen are all components of tumor promotional microenvironments, and thus may mediate promotion of breast cancers arising in the postpartum setting.

Citing Articles

From Embryogenesis to Senescence: The Role of Mammary Gland Physiology in Breast Cancer Risk.

Lue J, Radisky D Cancers (Basel). 2025; 17(5).

PMID: 40075637 PMC: 11898936. DOI: 10.3390/cancers17050787.


Molecular characterization of pregnancy-associated breast cancer and insights on timing from GEICAM-EMBARCAM study.

Pena-Enriquez R, Bermejo B, Pollan M, Diaz-Chacon A, Jerez Gilarranz Y, Ponce Lorenzo J NPJ Breast Cancer. 2025; 11(1):12.

PMID: 39922815 PMC: 11807221. DOI: 10.1038/s41523-025-00718-x.


Obesity and lack of breastfeeding: a perfect storm to augment risk of breast cancer?.

Ormiston K, Kulkarni A, Sarathy G, Alsammerai S, Shankar E, Majumder S Front Oncol. 2024; 14:1432208.

PMID: 39525621 PMC: 11543574. DOI: 10.3389/fonc.2024.1432208.


Immune Cell Contribution to Mammary Gland Development.

Vickers R, Porter W J Mammary Gland Biol Neoplasia. 2024; 29(1):16.

PMID: 39177859 PMC: 11343902. DOI: 10.1007/s10911-024-09568-y.


C/EBPβ deletion in macrophages impairs mammary gland alveolar budding during the estrous cycle.

Rojo M, Bandyopadhyay I, Burke C, Sturtz A, Phillips E, Matherne M Life Sci Alliance. 2024; 7(10).

PMID: 39025525 PMC: 11258408. DOI: 10.26508/lsa.202302516.


References
1.
Bladstrom A, Anderson H, Olsson H . Worse survival in breast cancer among women with recent childbirth: results from a Swedish population-based register study. Clin Breast Cancer. 2003; 4(4):280-5. DOI: 10.3816/cbc.2003.n.033. View

2.
Orimo A, Weinberg R . Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle. 2006; 5(15):1597-601. DOI: 10.4161/cc.5.15.3112. View

3.
Bemis L, Schedin P . Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion. Cancer Res. 2000; 60(13):3414-8. View

4.
Chie W, Hsieh C, Newcomb P, Longnecker M, Mittendorf R, Greenberg E . Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol. 2001; 151(7):715-22. DOI: 10.1093/oxfordjournals.aje.a010266. View

5.
Xu J, Rodriguez D, Petitclerc E, Kim J, Hangai M, Moon Y . Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol. 2001; 154(5):1069-79. PMC: 2196184. DOI: 10.1083/jcb.200103111. View